Myelodysplastic Syndromes and Secondary AML: An Update on Diagnosis and Treatment

Secondary AML Through the Microscope: A Pathology-Informed Guide to Modern Diagnostic and TreatmentПодробнее

Myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathologyПодробнее

Myelodysplastic Syndromes and Secondary AML– Update on Diagnosis and TreatmentПодробнее

The future of AML and MDS diagnosis and treatmentПодробнее

AON 2024 | Leukemia and Myelodysplastic Syndromes — Harry Paul Erba, MD, PhDПодробнее

Updates in the Myelodysplastic Syndromes: 2023 Best of HematologyПодробнее

What is secondary acute myeloid leukemia, or secondary AML?Подробнее

Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and managementПодробнее

Myelodysplastic Syndromes (MDS): Symptoms, Diagnosis, and TreatmentПодробнее

Treatment of AML With Myelodysplasia-Related ChangesПодробнее

MDS/AML Overlap and Novel Therapies with Dr. Naval DaverПодробнее

Secondary AML outcomesПодробнее

ASH 2019 The Latest in MDS and Secondary AMLПодробнее

Excerpt: Updates from ASH 2019: The Latest in MDS and Secondary AML 4/2/20Подробнее

Updates in the diagnosis, risk stratification & treatment of AML: WHO, ICC, and ELN classificationsПодробнее

Understanding the Recent WHO MDS Classification UpdatesПодробнее

MDS - Myeloplastic Syndromes - 2023 Best of Hematology ConferenceПодробнее

The WHO Updated Diagnostic Criteria for MPNПодробнее

What is the outlook for AML-MRC, tAML, and secondary AML?Подробнее